RE:RE:RE:RE:RE:somethings gotta give...CancerSlayer I agree too that timeliness have a way of being longer...way longer. Only consideration giving this hope of a faster turnaround for me is the delays with patient numbers may have given time for the homework to already be done. I wonder if the decision to proceed with a JV is only waiting for the BTD approval. Merck. Roche. Whoever has been watching this procedure/compound evolve doesn't want to be 2nd guy through the door with a cheque book to be looking at the go getter signing a deal. Simplistic visual but you get my point. PDT is the new frontier and Theralase almost has a bow on this package, ready to serve. I am hopeful this is the scenario.